Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 4/28/06 AVI BioPharma Announces 2006 First Quarter Financial Results Conference Call 4/21/06 AVI BioPharma to Present at UBS Global Specialty Pharmaceuticals Conference 4/20/06 AVI BioPharma Provides Update on Hepatitis C Virus Clinical Trial Status 3/30/06 AVI BioPharma Reports Successful Inhibition of Multiple Subtypes of Influenza A Using NEUGENE Antisense Therapeutic 3/13/06 AVI BioPharma and Cook Group Enter Into License Agreement to Develop NEUGENE Drugs for Vascular Diseases 3/10/06 AVI BioPharma Incorporated 2005 Fourth Quarter and Year–End Financial Results Conference Call Transcript 3/8/06 AVI BioPharma Announces 2005 Fourth Quarter and Full Year Financial Results 3/7/06 AVI BioPharma Successful Ebola Study Results Highlighted in Nature Reviews Drug Discovery 3/1/06 AVI BioPharma Announces 2005 Fourth Quarter and Year End Financial Results Conference Call 2/9/06 Successful Muscular Dystrophy Treatment Results Using AVI BioPharma Technology Published in Nature Medicine Pagination First page « first Previous page ‹ previous … Page 74 Page 75 Page 76 Page 77 Page 78 Page 79 Page 80 Current page 81 Page 82 Next page next › Last page last » Displaying 801 - 810 of 815 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 4/28/06 AVI BioPharma Announces 2006 First Quarter Financial Results Conference Call 4/21/06 AVI BioPharma to Present at UBS Global Specialty Pharmaceuticals Conference 4/20/06 AVI BioPharma Provides Update on Hepatitis C Virus Clinical Trial Status 3/30/06 AVI BioPharma Reports Successful Inhibition of Multiple Subtypes of Influenza A Using NEUGENE Antisense Therapeutic 3/13/06 AVI BioPharma and Cook Group Enter Into License Agreement to Develop NEUGENE Drugs for Vascular Diseases 3/10/06 AVI BioPharma Incorporated 2005 Fourth Quarter and Year–End Financial Results Conference Call Transcript 3/8/06 AVI BioPharma Announces 2005 Fourth Quarter and Full Year Financial Results 3/7/06 AVI BioPharma Successful Ebola Study Results Highlighted in Nature Reviews Drug Discovery 3/1/06 AVI BioPharma Announces 2005 Fourth Quarter and Year End Financial Results Conference Call 2/9/06 Successful Muscular Dystrophy Treatment Results Using AVI BioPharma Technology Published in Nature Medicine Pagination First page « first Previous page ‹ previous … Page 74 Page 75 Page 76 Page 77 Page 78 Page 79 Page 80 Current page 81 Page 82 Next page next › Last page last » Displaying 801 - 810 of 815